Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRHa versus mifepristone for symptomatic endometriosis
ChiCTR2000031689Phase 4Recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gonadotropin-releasing hormone agonist and mifepristone in endometriosis (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: Pain score, Change in menstrual volume and 6 more. Started Apr 2020; status: recruiting.
02
Drugs
gonadotropin-releasing hormone agonistmifepristone
03
Conditions
endometriosis
Beyond the preview
Go deeper on ChiCTR2000031689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031689.